{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:50:02Z","timestamp":1778874602008,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T00:00:00Z","timestamp":1585958400000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.stem.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T12:34:22Z","timestamp":1554381262000},"page":"506-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening"],"prefix":"10.1016","volume":"24","author":[{"given":"Anna","family":"Hnatiuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Mercola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2019.03.013_bib1","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.stem.2019.03.013_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coph.2018.07.003","article-title":"Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?","volume":"42","author":"Bruyneel","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.stem.2019.03.013_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","article-title":"Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells","volume":"9","author":"Drawnel","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.stem.2019.03.013_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2019.01.013","article-title":"MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in\u00a0vivo","volume":"24","author":"Fiedler","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2019.03.013_bib5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2015.03.016","article-title":"Cardiovascular drug development: is it dead or just hibernating?","volume":"65","author":"Fordyce","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.stem.2019.03.013_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/d41573-019-00014-x","article-title":"2018 FDA drug approvals","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.stem.2019.03.013_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2017.03.021","article-title":"The NextGen Genetic Association Studies Consortium: A Foray into In\u00a0Vitro Population Genetics","volume":"20","author":"Warren","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2019.03.013_bib8","series-title":"Fact Sheet number 310","article-title":"The top 10 causes of death","year":"2018"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590919301122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590919301122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:46:41Z","timestamp":1761832001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590919301122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1934590919301122"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2019.03.013","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2019.01.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}